Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study.
Gadoev J, Asadov D, Tillashaykhov M, Tayler-Smith K, Isaakidis P, Dadu A, de Colombani P, Gudmund Hinderaker S, Parpieva N, Ulmasova D, Jalolov A, Hamraev A, Ali E, Boom Mv, Hammerich A, Gozalov O, Dara M. Gadoev J, et al. Among authors: gozalov o. PLoS One. 2015 Jun 15;10(6):e0128907. doi: 10.1371/journal.pone.0128907. eCollection 2015. PLoS One. 2015. PMID: 26075615 Free PMC article.
Tuberculosis Notification Trends and Treatment Outcomes in Penitentiary and Civilian Health Care Sectors in the WHO European Region.
Dadu A, Ciobanu A, Hovhannesyan A, Alikhanova N, Korotych O, Gurbanova E, Mehdiyev R, Doltu S, Gozalov O, Ahmedov S, Dara M. Dadu A, et al. Among authors: gozalov o. Int J Environ Res Public Health. 2021 Sep 10;18(18):9566. doi: 10.3390/ijerph18189566. Int J Environ Res Public Health. 2021. PMID: 34574488 Free PMC article.
Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016-2018.
Buziashvili M, Davtyan H, Sereda Y, Denisiuk O, Gozalov O, Lomtadze N, Hovhannesyan A. Buziashvili M, et al. Among authors: gozalov o. Monaldi Arch Chest Dis. 2021 Jan 14;91(1):10.4081/monaldi.2021.1649. doi: 10.4081/monaldi.2021.1649. Monaldi Arch Chest Dis. 2021. PMID: 33470083 Free PMC article.
Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019-2020.
Avaliani T, Sereda Y, Davtyan H, Tukvadze N, Togonidze T, Kiria N, Denisiuk O, Gozalov O, Ahmedov S, Hovhannesyan A. Avaliani T, et al. Among authors: gozalov o. Monaldi Arch Chest Dis. 2021 Jan 14;91(1):10.4081/monaldi.2021.1679. doi: 10.4081/monaldi.2021.1679. Monaldi Arch Chest Dis. 2021. PMID: 33470088 Free PMC article.
What is behind programmatic treatment outcome definitions for tuberculosis?
Avaliani Z, Gozalov O, Kuchukhidze G, Skrahina A, Soltan V, van den Boom M, Vasilyeva I, Vilc V, Yedilbayev A. Avaliani Z, et al. Among authors: gozalov o. Eur Respir J. 2020 Jul 23;56(1):2001751. doi: 10.1183/13993003.01751-2020. Print 2020 Jul. Eur Respir J. 2020. PMID: 32703821 Free article. No abstract available.